- Home
- AMBA vs CPRX Comparison
AMBA vs CPRX Comparison
Compare AMBA & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBA
- CPRX
- Stock Information
- Founded
- AMBA 2004
- CPRX 2002
- Country
- AMBA United States
- CPRX United States
- Employees
- AMBA N/A
- CPRX N/A
- Industry
- AMBA Semiconductors
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMBA Technology
- CPRX Health Care
- Exchange
- AMBA Nasdaq
- CPRX Nasdaq
- Market Cap
- AMBA 2.3B
- CPRX 2.8B
- IPO Year
- AMBA N/A
- CPRX 2006
- Fundamental
- Price
- AMBA $63.62
- CPRX $21.48
- Analyst Decision
- AMBA Buy
- CPRX Strong Buy
- Analyst Count
- AMBA 11
- CPRX 7
- Target Price
- AMBA $74.09
- CPRX $31.14
- AVG Volume (30 Days)
- AMBA 337.4K
- CPRX 1.1M
- Earning Date
- AMBA 11-26-2024
- CPRX 11-06-2024
- Dividend Yield
- AMBA N/A
- CPRX N/A
- EPS Growth
- AMBA N/A
- CPRX 114.68
- EPS
- AMBA N/A
- CPRX 1.18
- Revenue
- AMBA $220,408,000.00
- CPRX $460,482,000.00
- Revenue This Year
- AMBA $20.11
- CPRX $21.99
- Revenue Next Year
- AMBA $19.21
- CPRX $17.95
- P/E Ratio
- AMBA N/A
- CPRX $18.22
- Revenue Growth
- AMBA N/A
- CPRX 32.17
- 52 Week Low
- AMBA $39.69
- CPRX $13.00
- 52 Week High
- AMBA $65.88
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- AMBA 64.29
- CPRX 48.92
- Support Level
- AMBA $56.40
- CPRX $20.87
- Resistance Level
- AMBA $59.25
- CPRX $21.63
- Average True Range (ATR)
- AMBA 2.10
- CPRX 0.77
- MACD
- AMBA 0.22
- CPRX -0.22
- Stochastic Oscillator
- AMBA 97.36
- CPRX 27.15
About AMBA Ambarella Inc.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.